MRC Epidemiology Unit

 

Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.

Abbasi A, Corpeleijn E, Gansevoort RT, Gans RO, Struck J, Schulte J, Hillege HL, van der Harst P, Stolk RP, Navis G, Bakker SJ

Diabetologia. Feb 2014

(DOI : 10.1007/s00125-014-3278-9)

---